ArticleCancer immunology, immunotherapy : CII2019

Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy.

Chris D Zahm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.